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GaLVThe R peptide in the cytoplasmic tail (C-tail) of γ-retroviral envelope proteins (Env) prevents membrane
fusion before budding. To analyse its role in the formation of replication competent, infectious particles, we
developed chimeric murine leukaemia viruses (MLV) with unmodiﬁed or R-peptide deleted Env proteins of
the gibbon ape leukaemia virus (GaLV). While titres of these viruses were unaffected, R-peptide deﬁciency led
to strongly impaired spreading. Most remarkably, we isolated an escape mutant which had restored an open
reading frame for a C-terminal extension of the truncated C-tail. A reconstituted virus encoding this escape C-
tail replicated in cell culture. In contrast to R-peptide deﬁcient Env, particle incorporation of the escape Env
was effective due to an enhanced protein expression and restored intracellular co-localisation with Gag
proteins. Our data demonstrate that the R peptide not only regulates membrane fusion but also mediates
efﬁcient Env protein particle incorporation in γ-retrovirus infected cells.y, Paul-Ehrlich-Institut, Paul-
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The surface glycoproteins of enveloped viruses have evolved to
accomplish many different functions. Their extracellular parts bind
the cellular receptor and mediate fusion of the viral and cellular
membranes to allow entry of the virus core into the cytoplasm.
Although being usually short in sequence, multiple functions have
also been suggested for the intracellular parts of viral envelope
proteins. The Env protein of γ-retroviruses is expressed as a
polyprotein which is cleaved into the surface unit (SU) and the
transmembrane unit (TM) during transport to the cell surface. While
SU is responsible for receptor attachment, TM tethers Env within the
membrane and bears the fusion peptide that penetrates into the
target cell membrane during cell entry. The intracellular part of TM
covers in its C-terminal half the R-peptide, an essential component of
the complex machinery that controls the membrane fusion activity of
Env (Bobkova et al., 2002; Loving et al., 2008).
There is increasing biochemical evidence that the R peptide plays a
critical role not only in membrane fusion but also in the assembly of
replication competent, infectious particles. Cleaved R peptide was
detected in Gag complexes within cells and evidence for a physical
association with Gag has been collected (Andersen et al., 2006). On
the other hand, particles assemble also in absence of the R peptide, i.e.R-peptide deﬁcient Env proteins become efﬁciently incorporated into
particles and mediate unimpaired infectivity (Aguilar et al., 2003;
Kubo and Amanuma, 2003; O'Reilly and Roth, 2003). However, in
these studies split package constructs were applied, which result in a
strong over-expression of Env protein. Under these conditions, also
particles carrying heterologous retroviral Env proteins can be
generated, as for example murine leukaemia virus (MLV)–gibbon
ape leukaemia virus (GaLV) Env protein pseudotypes (von Kalle et al.,
1994). Compared to infected cells, where Env is expressed in much
lower quantities, this approach reﬂects a rather artiﬁcial situation.
Hypothesising that the R peptide is critical for particle formation in
infected cells but not when Env is over-expressed, we analysed a
panel of chimeric viruses consisting of MLV core and either R-peptide
deﬁcient or full-length GaLV Env variants. We found that the R
peptide was essential for virus replication and that R-peptide
deﬁciency resulted in a strong selective pressure which gave rise to
escape mutants, which had reconstituted a C-tail composed of an R-
peptide unrelated sequence. In contrast to R-peptide deﬁcient viruses,
particle assembly of the escape virus was effective also at low Env
protein levels due to a restored intracellular co-localisation with Gag.
Results
Generation of chimeric MLV–GaLV viruses
We constructed chimeric retroviruses composed of the Moloney
MLV core and two GaLV Env variants available in our lab (Fig. 1A)
which differed in a single amino acid residue at position 217 (N or Y).
This residue localises to the proline rich region of Env, which is
Fig. 1. Chimeric viruses and growth kinetics. (A) Genomic organisation of the chimeric MLV–GaLV virus and sequence of the GaLV Env C-tail. MD:membrane spanning domain, MPD:
membrane proximal domain of the C-tail remaining after R-peptide (R-pep) cleavage. In the sequence of the C-tail, the following potential sorting signals are indicated: the di-
leucine motif LΦ where Φ is any hydrophobic amino acid (dotted line), the tyrosine motif YxxΦ (dashed line) and the viral cleavage site (arrow; solid line indicates protease
recognition sequence). (B) Spreading of the chimeric MLV–GaLV variants (black: MLV–GaLV; white: MLV–GaLVN217Y) and aMLV (grey) on HT1080 (solid lines) and Vero cells
(dashed lines). Cells were infected with an m.o.i. of 0.004. At the indicated time points the percentage of infected cells was determined by immunostaining for p30.
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Roth, 2003), and where some variations in the published GaLV
sequences can be found. As the replication kinetics of the respective
indeed differed (Fig. 1B), we investigated both viruses further.
For the R-peptide deleted variants the complete R-peptide reading
frame was removed in both GaLV Env proteins resulting in the viruses
MLV–GaLVΔR and MLV–GaLVN217YΔR. Virus stocks were produced by
transfection of HEK-293T cells with the virus coding plasmids. The
deletion of the R peptide and its coding sequence was conﬁrmed by
western blot analysis and RT-PCR (data not shown). As a further
obvious indication for R-peptide loss, the HEK-293T cells transfected
with plasmids pMLV–GaLVΔR and pMLV–GaLVN217YΔR formed large
syncytia indicating uncontrolled fusion activity of the Env proteins
without R peptide (Fig. 2A left panel and data not shown). Titration of
virus stocks harvested from the transfected HEK-293T revealed
slightly reduced titres for the variants carrying the N217Y mutation
(MLV–GaLVN217Y: 2×104 i.u./ml; MLV–GaLVN217YΔR: 7×104 i.u./ml;
MLV–GaLV: 7×105 i.u./ml; MLV–GaLVΔR: 4×105 i.u./ml). While R-
peptide deﬁciency had no effect on titres, it resulted in the formation
of syncytia covering 10–20 nuclei when HT1080 cells were infected
with MLV–GaLVΔR or MLV–GaLVN217YΔR (Fig. 2A, right panel).
Replication of chimeric MLV–GaLV viruses
To assess the replication competence of the MLV–GaLV viruses, we
compared their spreading capacity in cell culture to that of an
amphotropic MLV (aMLV) with a Moloney MLV core. HT1080 or Vero
cells were infected at an m.o.i. of 0.004 and the percentages of infected
cells, as well as the released reverse transcriptase (RT) activities were
determined at several timepoints. The replication kinetics of bothMLV–GaLV viruses was reduced, especially on Vero cells. On HT1080 cells
about one-third of the cells that had been infected with aMLV had
becomeMLV–GaLV positive at day three after infection. However, both
viruses were able to infect 100% of the cells within nine days of
cultivation (Fig. 1B, solid lines). OnVero cells, the reduction in spreading
efﬁciency of the chimeric viruses was more pronounced. Here, only the
MLV–GaLVN217Y virus was able to infect 100% of cells (Fig. 1B, dashed
lines). Similar kinetics were obtained for the released RT-activities.
Maximal levels obtained were 104 mU/ml on HT1080 and 103 mU/ml
on Vero cells (data not shown). Altogether, the MLV–GaLV and MLV–
GaLVN217Y virus chimaeras were replication-competent. The slight
advantage of MLV–GaLVN217Y during replication on Vero cells indicates
that the N217Y substitution in the PRR region might be beneﬁcial for
replication under certain conditions.
The R-peptide deﬁcient viruses in contrast were strongly impaired
in spreading through HT1080 cells. After three days both viruses had
infected a few cells and RT-activity in the cell culture medium was
detectable. From that day on, RT values forMLV–GaLVΔR declined and
were below the detection limit by day 15. From day 20 on, infected
cells were not detectable any more (Fig. 2B; closed symbols). MLV–
GaLVN217YΔR, in contrast, showed a very low but signiﬁcant level of
replication. The number of infected cells steadily increased over a
period of more than 20 days to about 10%, RT levels raised from 7 to
62 mU/ml (Fig. 2B; open symbols). Interestingly, the amount and size
of syncytia detectable in the cell layer decreased during this period
(data not shown). After day 25, RT activity as well as the number of
infected cells increased rapidly and reached 100% infected cells and an
RT activity of about 104 mU/ml within 10 days (Fig. 2B). This sudden
occurrence of replication competent virus could most likely be
explained by the rise of mutants within the virus population.
Fig. 2. Infection and growth kinetic of R-peptide deﬁcient viruses. (A) Syncytia formation after transfection of pMLV–GaLVN217YΔR in HEK-293T cells (left) and after infection of
HT1080 cells with MLV–GaLVN217YΔR at day 9 post infection (right, infected cells stained). (B) Spreading of MLV–GaLVΔR (black) and MLV–GaLVN217YΔR (white) after infection of
HT1080 cells at anm.o.i. of 0.004. The percentage of infected cells (solid line) and RT activity in the cell culture supernatant (dotted line) was determined at the indicated time points.
(C) RT-PCR analysis of the viral env gene. Virus was harvested from the supernatant of MLV–GaLVN217YΔR infected cells at 38 days after infection (lanes 1 and 2) and at day 9 after
infection for viruses MLV–GaLVN217Y (lanes 3 and 4) and MLV–GaLV (lanes 5 and 6). RNA was puriﬁed and RT-PCR was performed using primers IH18 (cDNA) and IH18 and IH32
(DNA-Ampliﬁcation) (lanes 1, 3 and 5). Expected size of PCR-products from virus bearing the R peptide (wt) or without R peptide (ΔR) are indicated at the left side of the panel. To
exclude signals from plasmid DNA, RT-PCR was performed in absence of reverse transcriptase (lanes 2, 4 and 6). As positive control, DNA from pMLV–GaLV was used as template
(lane 7).
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To assess the possible occurrence of escape mutants within the
replicating virus population, we isolated viral RNA from culture
supernatants collected for the kinetic measurements of all viruses and
performed RT-PCR with primers ﬂanking the R-peptide coding
sequences. While a single PCR fragment of the expected size was
obtained for MLV–GaLV and MLV–GaLVN217Y, two bands of similar
intensities were obtained from the viruses present in the supernatant
of the MLV–GaLVN217YΔR infected cells after day 25 of cultivation. The
bottom band migrated at the expected size of 486 bp for the PCR
product of MLV–GaLVN217YΔR (Fig. 2C). The second PCR fragment was
larger (about 600 bp) than the PCR-products obtained from the R-
peptide coding viruses (531 bp) (Fig. 2C). Sequencing of the largerPCR product obtained from the MLV–GaLVN217YΔR infected cells at
day 38 of cultivation revealed the duplication of a 106 bp fragment of
the GaLV env gene located four nucleotides before the stop codon of
GaLVN217YΔR env (Fig. 3A). This insertion induced a frame shift
thereby elongating the env reading frame by 19 amino acid residues
(Fig. 3A). The resulting sequence has no similarity to any known R
peptide and is 4 amino acids longer than the GaLV R peptide. The
recognition site for R-peptide cleavage by the viral protease is also
affected by the mutation. A potential cleavage site could not be
identiﬁed.
To analyse the properties of this newly evolved R peptide (below
referred to as Resc peptide), we reconstituted an MLV–GaLVN217Yesc
virus by subcloning the Resc-peptide coding sequence into the MLV–
GaLVN217Y backbone, thereby excluding any effects on the viral
Fig. 3. Characterisation of the escape virus. (A) Genetic organisation of the TM coding region of the R-peptide deﬁcient virus (upper bar) and the escape virus (lower bar). The
duplicated DNA sequence is depicted in light grey, the dotted line indicates the frameshift occurring at the beginning of the duplicated DNA sequence, black lines and stars indicate
stop codons. The amino acid sequence of the C-tail is shown as well. (B) Spreading of the reconstituted escape virus in HT1080 cells. HEK-293T cells were transfected with pMLV–
GaLVN217Yesc (squares) or pMLV–GaLVN217YΔR (triangles). The transfected cells were then mixed with uninfected HT1080 cells at a ratio of 1:500. RT activity in the cell culture
supernatant was determined at the indicated time points. (C) RT-PCR analysis of viral RNA. Viral RNA was puriﬁed two days after transfection of HEK-293T cells (upper panel) or
21 days after infection of HT1080 cells (bottom panel). RT-PCR was performed using primers IH18 (cDNA) and IH18 and IH32 (DNA-ampliﬁcation) (lanes 1, 3, 6 and 7). To exclude
signals from plasmid DNA, RT-PCR was performed in absence of reverse transcriptase (lanes 2 and 4). As positive control (+), DNA from pMLV–GaLVN217Yesc (lane 5) and pMLV–
GaLVN217YΔR (lane 8) was used as template.
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viral genome during replication. The spreading capacity of MLV–
GaLVN217Yesc was analysed in an experimental setup with minimised
selective pressure: HEK-293T cells were transfected with the pMLV–
GaLVN217Yesc plasmid or with pMLV–GaLVN217YΔR as control (trans-
fection rate: 30–40%) and after two days the cells were detached and
cocultivated at a ratio of 1:500 with uninfected HT1080 cells. During
the next 21 days, MLV–GaLVN217Yesc showed continuously increasing
RT-values in the supernatant, as well as an increasing amount of
infected cells, indicating spreading of the virus throughout the
culture. In contrast, MLV–GaLVN217YΔR was not able to spread
under this experimental setup of low selective pressure.
Analysis of the genetic stability of the MLV–GaLVN217Yesc virus at
day 21 of the cocultivation revealed that the Resc-peptide coding
sequence had not changed. However, reminiscent of the situation in
the virus population after selection of the MLV–GaLVN217Yesc virus,
we detected a mixed virus population containing besides the escape
virus, a virus (although at a much lower level), in which the 106 bp
duplication had reverted and thus was identical in sequence to MLV–
GaLVΔR as conﬁrmed by sequencing (Fig. 3C, bottom panel). This
reverted virus was not detectable in the MLV–GaLVN217Yesc virus
stock implying that it must have occurred during virus propagation
(Fig. 3C, top panel).
We observed that theMLV–GaLVN217Yesc transfectedHEK-293T cells
as well as the cocultivated cells formed syncytia to a comparable degree
as MLV–GaLVN217YΔR positive cells. Also, in a quantitative reporter cell
fusion assay expression of GaLVN217YΔR–Env and GaLVN217Yesc–Env
resulted in comparable fusion activities, being 190-fold and 150-fold
more fusogenic than theR-peptide bearingGaLVN217Y–Env, respectively,
at similar cell surfaceexpression levels as determinedbyﬂowcytometric
analysis (data not shown).Effect of the R peptide on Env protein incorporation into virus particles
Our observation that the deletion of the R peptide impairs
spreading of virus after infection but not the production of viruses
by transfection as well as the occurrence of an R-peptide variant that
allows spreading, hints to a difference in Env incorporation in
transfected versus infected cells. Since transfection usually results in
a much higher copy number of provirus per cell than infection, we
studied the inﬂuence of the amount of plasmid used for transfection
on infectivity of produced particles and the amount of incorporated
Env protein. Three different amounts of plasmid encoding MLV–
GaLVN217YΔR, MLV–GaLVN217Y, or MLV–GaLVN217Yesc were trans-
fected into HEK-293T cells and after 2 days, virus released from
the cells was quantiﬁed. Titres differed considerably (Figs. 4A and B,
left panel) although similar amounts of RT-activity were released
into the supernatants (Fig. 4B, right panel). Especially, the titre of
MLV–GaLVN217YΔR decreased dramatically from about 106 i.u./ml to
below 103 i.u./ml when 1 μg instead of 3 μg of plasmid DNA was
transfected. In contrast to that, the titres of MLV–GaLVN217Y andMLV–
GaLVN217Yesc only dropped 10-fold to about 5×104 i.u./ml. At
0.2 μg of transfected plasmid DNA, infectivity of MLV–GaLVN217YΔR
was completely lost, while released particles could still be detected by
RT-activity in the supernatant. At this condition, infectious virus was
only detectable for the MLV–GaLVN217Y and MLV–GaLVN217Yesc
viruses.
To correlate the observed titres to the incorporation of Env protein
into virions, we generated MLV vector particles in presence of
different amounts of the three GaLV Env variants. We assessed Env
incorporation by western blot analysis of puriﬁed particles using a
MLV Env-speciﬁc antibody that cross reacts to GaLV TM. When high
amounts of Env expression plasmid were transfected, all three TM
Fig. 4. Inﬂuence of Env expression levels on infectivity and Env particle incorporation. (A) HEK-293T cells were transfected with the indicated amounts of plasmids MLV–
GaLVN217YΔR (left panel), MLV–GaLVN217Yesc (centre panel) and pMLV–GaLVN217Y (right panel) to produce virus stocks, which were used to infect HT1080 cells. The infected cells
were permeabilised and stained for p30 two days after infection. Representative bright ﬁeld images of infected HT1080 cells at 10×magniﬁcation are shown. (B) Infectious titres (left
panel) and RT activities (right panel) of the virus stocks of MLV–GaLVN217Y (black), MLV–GaLVN217Yesc (grey) and MLV–GaLVN217YΔR (white) produced from the indicated amounts
of transfected plasmid DNA as before. One of two performed experiments with similar results is shown. (C) Env incorporation into vector particles and expression in cell lysate.
Vector particles were produced by transfection of HEK-293T cells with plasmids pHit60 (12 μg), and the indicated amounts of plasmids pMSCV–GaLV-HA (wt), pMSCV–GaLVΔR (ΔR)
or pMSCV–GaLVN217Yesc (esc), respectively. Plasmid DNA from pUC19 was used to adjust all transfection samples to a total amount of 18 μg of plasmid DNA. Two days after
transfection, particles were harvested from serum-free medium, concentrated by ultracentrifugation and used for western blot analysis with antibodies speciﬁc for TM protein or
p30. The R-peptide processed form of TM became detectable after long-term exposure for the Env variant with the unmodiﬁed C-tail upon transfection of 6 μg plasmid DNA (lane wt,
bottom left panel, vector particles). Lysates of the transfected cells were analysed by western blot using an antibody detecting the HA-tag at the Env N-terminus and the p30 speciﬁc
antiserum. All samples were loaded on a single gel, analysed on a single blot and exposed for the same time period.
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lower amounts for GaLVN217YΔR Env (Fig. 4C, top panel). Even after
long exposure, TM protein was detected as a single band in case of
GaLVN217YΔR and GaLVN217Yesc Env, while low levels of R-peptide
deﬁcient TM for GaLVN217Y Env became detectable only then,
reﬂecting a low level of R-peptide processing by the MLV protease
(Fig. 4C, bottom panel, vector particles) (Merten et al., 2006). When
lower levels of Env expression plasmid were used, longer exposure
periods were necessary to allow TM protein detection. Yet, the result
was clear-cut: Upon transfection of 2 μg plasmid DNA, GaLVN217YΔR
Env was no longer detectable in viral particles, whereas GaLVN217Yesc
Env was incorporated with similar efﬁciency as GaLVN217Y Env(Fig. 4C, centre panel, vector particles). Only whenwe further reduced
the plasmid amounts, incorporation of GaLVN217Yesc Env failed, while
the GaLVN217Y TM protein was still detectable (Fig. 4C, right panel,
vector particles). Western blot analysis of cellular lysates from the
transfected packaging cells revealed that the Env expression levels
corresponded well with the amounts of plasmid used for transfection.
Moreover, expression levels of GaLVN217Yesc Env were generally
enhanced, indicating that the Resc-peptide potentially stabilises Env
and thereby raises its cellular expression level. Taken together, these
data demonstrate a defect in Env particle incorporation for the
GaLVN217YΔR virus, which can be overcome by over-expression of R-
peptide deﬁcient Env, as well as by the Resc peptide.
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We analysed the co-localisation of the three Env variants withMLV
Gag protein by immunoﬂuorescence microscopy. For protein detec-
tionwemade use of an HA-tag fused to the Env N-terminus and a YFP-
tagged variant of the MLV Gag polyprotein (Andrawiss et al., 2003).
The overall Env distribution patterns and the mean numbers of Env
signals per cell did not differ considerably between the three variants
and were unchanged upon Gag co-expression. All variants localised in
the perinuclear region, ER and Golgi, and in spots (vesicles) dispersed
throughout the cytoplasm, similar to MLV Env localisation described
previously (Sandrin and Cosset, 2006; Sandrin et al., 2004).
Co-localisation with Gag clearly differed between GaLVN217Y Env
and GaLVN217YΔR Env. In principle, these spots of overlapping Env and
Gag signals can be derived from assembling particles or particles
endocytosed after budding. While the cytoplasmic spots of Gag and
GaLVN217Y Env co-localised to a very high degree, co-localisation of
Gag and GaLVN217YΔR Env was considerably impaired, with only a
minor fraction of Env spots overlapping with the Gag signal (Fig. 5A).
There was a tendency for relatively more GaLVN217Yesc Env positive
spots to co-localise with Gag than GaLVN217YΔR Env positive spots.
This was conﬁrmed by quantitative results obtained from a computer-
based algorithm which determined the ratio of signals in both
channels (yellow spots in overlay) to the total number of red spots
(Env) on randomly chosen cells for each Env variant. Whereas half of
the GaLVN217Y Env positive spots co-localised with Gag, this was the
case for only 25% of the GaLVN217YΔR Env positive spots. GaLVN217Yesc
Env showed an intermediate phenotype of 35% of co-localised spots.
Although there were variations between individual cells, the
difference between the GaLVN217Y and GaLVN217YΔR phenotype asFig. 5. Intracellular co-localisation of Env and core particles. (A) Immunoﬂuorescence stain
pMSCV–GaLV-HA (left panel), pMSCV–GaLVΔR (centre panel) or pMSCV–GaLVN217Yesc (
Alexa594-labelled secondary antibody (red ﬂuorescence). Co-localisation of Gag and Env res
arrows point to typical spots: magenta to Env, cyan to Gag and white to co-localised Env/Gag
spots was determined for each GaLV Env variant. The p-values for wildtype (wt) versus ΔR (
variance analysis).well as that between GaLVN217Yesc and GaLVN217YΔR was statistically
signiﬁcant as determined by two-factorial variance analysis.Discussion
To elucidate the role of the R peptide during replication of γ-
retroviruses, we studied a set of chimeric viruses consisting of the
MLV core and variants of the GaLV Env protein with an intact or
deleted R-peptide coding sequence. The infectivity of virus stocks
produced by transfection of HEK-293T cells was unaffected by R-
peptide deﬁciency. This is well in agreement with the production of
MLV vector stocks which usually reach similar titres when Env
proteinswith orwithout R-peptide have been used (O'Reilly and Roth,
2003). For virus spreading, in contrast, the R-peptide was absolutely
indispensable. Interestingly, we identiﬁed different threshold levels of
plasmids encoding R-peptide containing and deﬁcient Env proteins
required for particle incorporation and infectivity. Thus, the R peptide
is necessary to mediate efﬁcient particle incorporation when Env
protein levels are relatively low as in infected cells, while it is
dispensable in vector packaging cells generated by transfection of
large amounts of Env encoding plasmid DNA. Accordingly, Env
incorporation in virus infected cells and vector packaging cells is
most likely governed by distinct molecular mechanisms.
The most interesting observation of this study was the appearance
of a virus variant which had escaped from R-peptide deﬁciency. This
escape virus had restored an open reading frame for a C-terminal
extension of the truncated C-tail. The resulting peptide was of similar
length as the R peptide, but its sequence was completely different. A
reconstituted escape virus generated by subcloning of the Resc-ing of HeLa cells co-transfected with pMLV-gag-yfp (green ﬂuorescence) and plasmids
right panel), respectively. Env was detected via an HA-tag speciﬁc antibody and an
ulted in yellow spots. Pictures were taken with LSM Axiovert. In the enlarged detail view
spots. (B) The ratio of the number of co-localising spots and the number of Env derived
0.0068) and escape (esc) versus ΔR (0.0383) were statistically signiﬁcant (two-factorial
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replication competent and able to spread through cultivated cells.
The escape virus resulted from a tandem duplication of a 106 bp
fragment normally encoding the transmembrane domain and the
membrane proximal half of the C-tail of the GaLV Env protein. This
type of mutation is most likely due to homologous recombination
between the two packed genomes resulting from template switching
of the reverse transcriptase (Mikkelsen et al., 1996; Roda et al., 2003).
When the escape virus was detected, roughly similar amounts of the
escape virus and the parental R-peptide deﬁcient virus were present
in the cell culture supernatant. The R-peptide deﬁcient virus was also
detected in cells infected with the reconstituted escape virus – though
at amuch lower level –which is well conceivable due to the instability
of tandem duplications.
As the Resc peptide had no inhibitory effect on cell–cell fusion
mediating efﬁcient incorporation of Env into virus particles seems to be
the key function of theResc peptide for virus spreading. Here presumably
the slightly enhanced expressionof Envesc and its enhanced co-localising
with gag act jointly for an enhanced incorporation. The data from
infectious virus and vector particles producedwith different amounts of
plasmid both indicate that the threshold of Env expression allowing
formation of infectious particles depends of the R-peptide sequence.
The trafﬁcking of Env between secretory vesicles, cell surface and
endosomal vesicles is determined by different signals in the Env
cytoplasmic tail. The di-leucine motif (LΦ, whereΦ is any hydrophobic
amino acid) and the tyrosine motif (YxxΦ) control cycling between
endosomes and the transgolgi network through interactions with
different adaptor proteins (e.g. AP1, 2 and 3), as demonstrated for the
MLV andMason–Pﬁzer monkey virus (MPMV) Env proteins (Blot et al.,
2006). While, due to its location in the membrane proximal part of the
C-tail, the di-leucinemotif is retained in the Envesc protein, the tyrosine-
based motif is absent from the Resc-peptide. Instead, the Resc peptide
comprises a proline-rich sequence (PITPP), which fulﬁls the PXXP
consensus for SH3 domain binding sites (Feng et al., 1994; Kaneko et al.,
2008). Such adaptor protein binding motives are well known in Gag
proteins of many retroviruses for example the PTAP late domain of HIV,
that is essential for its interaction with the ESCRT system of the cell
(Freed, 2002; Morita and Sundquist, 2004). A possible explanation for
the enhanced co-localisation of the Envesc protein with Gag could thus
involve the coordinated binding of Envesc and Gag to adapter proteins,
which mediate their close contact for incorporation. While further
experimental evidence will be required to completely understand the
molecular mechanism behind particle incorporation of the Envesc
variant, the genetic organisation of the escape virus nicely illustrates
the power of virus evolution. Rancurel and colleagues published viral
strategies giving rise to “protein birth” by overlapping genes. By what
they called “overprinting”, viruses create new polypeptides by frame
shift mutations within a coding sequence. The sequences of such
overlapping proteins are unusual in being composed of a high
proportion of disorder-promoting amino acid residues (Rancurel et al.,
2009). This applies perfectly well to the situation for the Resc peptide:
the tandem duplication resulted in the translation of oneDNA sequence
in twodifferent reading frames andwithin the 20 aminoacids of theResc
peptide eight are disorder-promoting residues, i.e. proline or histidine.
Taken together our data suggest that the coding sequence of the GaLV
Env transmembrane domain has hidden genetic capacity available for
an alternative R peptide that fulﬁls at least in part the functions of the
original R peptide.
Materials and methods
Plasmids and primers
All plasmids encoding MLV–GaLV variants were derived from pC-AK-
A, coding for a chimeric virus composed of a variant of amphotropic MLV
Envand theMoloney-MLVcore (Hartl et al., 2005). AnadditionalMluI-sitewas inserted between the env-gene and the 3′-LTR. To exchange the env
gene in pC-AK-A, the GaLVN217Yenv gene was ampliﬁed by PCR from
pHGIN(Mertenet al., 2005)withprimers IH16(5′-GAGCATCGTGGCCCA
GCC GGC CAG TCT GCA AAA TAA GAA CC-3′) and IH31 (5′-CAC TGA CTA
CGCGTTTAAAGGTTACC-3′) or IH33 (5′-CACTGACTACGCGTTTACAGA
ATT TTA ACC G-3′) for the R-peptide deleted variant. The PCR fragments
were then inserted into pC-AK-A via the SﬁI/MluI restriction sites
(underlined in the primer sequence), to obtain pMLV–GaLVN217Y and
pMLV–GaLVN217YΔR. To construct pMLV–GaLV and MLV-GaLVΔR the
SnaBI/PacI fragment frompMLV–GaLVN217Y and pMLV–GaLVN217YΔRwas
exchanged against that of pMOV–GaLV (Delassus et al., 1989). The
plasmid pM91MS coding for aMLV within the same backbone as the
chimeric viruses was previously described (Hartl et al., 2005).
The GaLVN217Y and GaLVN217YΔR Env expression plasmids used for
immunoﬂuorescence and western blot analysis were previously
described as pMSCV–GaLV-HA and pMSCV–GaLV-ΔR (Merten et al.,
2006). Plasmid pMSCV–GaLVN217Yesc was cloned via exchange of the
PacI/HincII fragmentof pMSCV–GaLV-HAagainst thePacI/MluI fragment
of pMLV–GaLVN217Yesc after Klenow ﬁll-in of the MluI site. Plasmids
encoding the Gag-Pol protein (pHit60) and the Gag-YFP protein
(pMLVgag-yfp) were previously described (Andrawiss et al., 2003;
Soneoka et al., 1995).
Cell culture and virus production
HT1080 (human ﬁbrosarcoma; ATCC, CCL-121), HEK-293T
(human embryonic kidney; originally referred to as 293tsA1609neo),
Vero (ATCC, CCL-81) and HeLa (ATCC, CCL-2) cell lines were grown in
DMEM supplemented with 10% foetal calf serum (FCS; GIBCO™),
10 mM L-Glutamine, benzylpenicillin (60 μg/ml) and streptomycin
(100 μg/ml). All cells were grown at 37 °C in an atmosphere of 5% CO2.
For viral particle production 4×106 HEK-293T cells were transfected
with 14 μg of viral plasmid DNA using Lipofectamin Plus (Invitrogen)
according to the manufacturer's instructions.
RT-PCR, sequencing and reconstruction of pMLV–GaLVN217Yesc
RNA was isolated from particles harvested from the culture
supernatant at several days after infection of HT1080 cells with
MLV–GaLVN217YΔR. RT-PCR was performed with the primer IH18 for
cDNA generation and primers IH32 (5′- CCT CCA AGA CTC AGT CAG
CAA GTT AG -3′) or dRVariantePac(+) (5′- CAA CTG CCT TAA TTA AAG
GAC CTA TAG ACC TCC AGC -3′) and IH18 (5′- GTG CAT GCT AGC TTG
CCA AAC CTA CAGG -3′) for ampliﬁcation of the DNA. The PCR product
of dRVariantePac(+) and IH18 from day 38 was subcloned into the
pGEM®-T Easy vector for sequencing of individual bacterial clones
with the primer IH18. The Resc-peptide coding sequence was inserted
into the pMLV–GaLVN217Y backbone via PacI/MluI.
Immune peroxidase-assay and RT assay
Infectious particles released from HEK-293T cells were quantiﬁed
by titration on HT1080 cells, followed by an immune peroxidase
staining of infected cells after 30 h using the goat anti RLV-p30 serum
(ATCC-Nr. VR-1564AS-Gt), as previously described (Buchholz et al.,
1998). RT activity was determined using the C-type-RT Activity Assay
(Cavidi Tech) according to the manufacturer's instructions.
Western blot
Virus particles were harvested from serum-free medium of HEK-
293T cells transfected with in total 18 μg of DNA (12 μg pHit60, the
indicated amount of Env expression plasmid supplementedwith pUC19
DNA to 6 μg) and then concentrated by ultracentrifugation in an SW41
rotor (Beckman) at 30,000 rpm for 1 h at 4 °C. The producer cells were
lysed in 250 μl RIPA lysis buffer (25 mM Tris pH 8, 137 mM NaCl, 10%
92 I.C. Schneider et al. / Virology 418 (2011) 85–92glycerol, 0.1% SDS, 0.5% NaDOC, 1% NP40, 2 mM EDTA). Virus collected
from 11 ml supernatant was then suspended in 100 μl of cold PBS,
separated by electrophoresis on a 10% SDS-polyacrylamide gel, and
electro transferred onto a nitrocellulose membrane (Hybond ECL,
Amersham). Themembraneswere probedwith hybridoma supernatant
containing the rat monoclonal antibody 42/114 against the TM of Env,
anti-HA-tag antibody 16B12 (Covance, diluted 1:1000) or anti RLV-p30
goat antisera (ATCC-Nr. VR-1564AS-Gt) as previously described and
incubatedwith HRP-conjugated rabbit anti-rat and anti-goat antibodies
(DAKO), respectively (Buchholz et al., 1998;Mertenet al., 2005). Protein
bands were visualised using ECL (Pierce).
Quantitative cell fusion reporter assay
Measurement of Env protein-mediated syncytia formation was
performed as described elsewhere (Holland et al., 2004). In brief, 1×106
HEK-293Tcellswere transfectedwithpCMV-α, encoding theα-subunit of
β-galactosidase, and the corresponding pMSCV–GaLV expression plasmid
(1.5 mg, each). In parallel, the same number of HEK-293T target cells was
transfected with 3 μg of pCMV-ω, expressing the ω-subunit of β-
galactosidase. Two days post transfection, the cells were harvested and
1×105 cells of each type were mixed and incubated in thin-walled PCR
tubes at 37 °C for the 5 h. Subsequently, cells were lysed in 100 μl lysis
buffer [100mM potassium phosphate (pH 7.8), 0.2% Triton X-100] and
10 μl of this solution was used for luminescent measurement of β-
galactosidase activity using GalactoStar reagents (Applied Biosystems)
and a microplate luminometer.
Immunoﬂuorescence and laser scan microscopy (LSM)
2×104 HeLa cells were seeded in LabTek I chambered coverglasses
with 0.8 cm2 culture area per well (Nunc) one day before transfection.
0.05 μg pMLV-gag-yfp, 0.075 μg pMSCV–GaLV plasmid coding the HA-
tagged Env variants and 0.125 μg pUC19 were transfected using 0.75 μl
Fugene (Roche)perwell according to themanufacturer's instruction.On
the next day, cells were ﬁxed with 4% formaldehyde in PBS for 20 min
and permeabilized with 0.1% Triton X-100 for 8 min at room
temperature and unspeciﬁc protein binding was blocked with 10%
chicken serum (Gibco) in PBS for 30 min at 37 °C. Env was stained with
the anti-HA antibody 16B12 (Covance) diluted 1:800 and anti-mouse
IgG1 antibody conjugated with Alexa594 (Invitrogen) diluted 1:250 in
blocking buffer, each for 1 h at 37 °C. YFP and Alexa594 ﬂuorescence
weredetectedusing thePlan-Apochromat Ph363xoil objective (NA1.4;
Zeiss) of a confocal laser scanning microscope (LSM 510 Meta, Zeiss).
YFP was excited with the 488 nm laser line of an argon laser (BP 505–
530), Alexa594with the543 nmHeNe laser line (BP560–615).One slice
of each cell near the maximum cell size at the bottom was analysed.
Semi-automated co-localisation analysis
Confocal microscopic pictures from several cells expressing a
ﬂuorescently tagged version of MLV Gag (green channel) and different
variants of GaLV-Env protein visualised with immunoﬂuorescence (red
channel) were analysed with a semi-automated plug-in compiled for
ImageJ (http://rsv.info.nih.gov/ij/). Brieﬂy, the images of each channel
were ﬁlteredwith a bandpassﬁlter, and two subsequent empirically set
thresholds of signal intensity were applied. Signals above this threshold
and with a size ranging from 2 to 200 pixels were detected in both
channels independently and coordinates plotted with deﬁned signal
intensity for each individual channel (i.e. 1 for a green spot, 2 for a red
spot). Combination of these images easily allows each spot to be
assigned single or double-labelled (3 for a signal in both channels). The
ratio of double-labelled spots over the total number of GaLV Env signal
spots was calculated as a measure for co-localisation of signals.Acknowledgments
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